alpha,beta-methyleneadenosine 5'-triphosphate has been researched along with Thromboembolism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaneo, M; Cazenave, JP; Evans, R; Gachet, C; Hechler, B; Kassack, MU; Magnenat, S; Ullmann, H; Zighetti, ML | 1 |
1 other study(ies) available for alpha,beta-methyleneadenosine 5'-triphosphate and Thromboembolism
| Article | Year |
|---|---|
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfon
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclases; Animals; Benzenesulfonates; Bleeding Time; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Epinephrine; Fibrinolytic Agents; Humans; In Vitro Techniques; Injections, Intravenous; Mice; Microscopy, Electron, Scanning; Oocytes; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Purinergic P2; Receptors, Purinergic P2X; Thromboembolism; Thrombosis; Xenopus laevis | 2005 |